Search results for "Antivirals"
Stronger warning for montelukast; COVID-19 actions
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/05/stronger-warning-for-montelukast-covid-19-actions.htm
1 May 2020
IDSA offers criteria on testing for COVID-19; new research looks at clots, treatments
The Infectious Diseases Society of America (IDSA) released guidance for COVID-19 testing among inpatients and outpatients, while studies offered further support for anticoagulation but showed no benefit from hydroxychloroquine or lopinavir-ritonavir.
https://immattersacp.org/weekly/archives/2020/05/12/1.htm
12 May 2020
Recent articles look at COVID-19 risk by blood type, ethical lessons, prone positioning
People in Italy and Spain with type A blood had increased risk of severe COVID-19, and prone positioning increased oxygenation, studies found. The FDA changed its position on hydroxychloroquine and ACP reaffirmed its stance.
https://immattersacp.org/weekly/archives/2020/06/23/1.htm
23 Jun 2020
Extended-release metformin recalled due to impurity
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/07/extended-release-metformin-recalled-due-to-impurity.htm
1 Jul 2020
Latest COVID-19 research on dexamethasone, hydroxychloroquine, a vaccine, tocilizumab
Peer-reviewed details on the recent trial of dexamethasone were released, and two new trials found no benefit to early treatment with hydroxychloroquine. Positive data from a phase 1 vaccine trial were also published, as was another study of tocilizumab.
https://immattersacp.org/weekly/archives/2020/07/21/1.htm
21 Jul 2020
Warning about hand sanitizer; labeling changes for opioids
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/09/warning-about-hand-sanitizer-labeling-changes-for-opioids.htm
1 Sep 2020
Best practices for HCV care include less invasive testing for many patients, says ACP
The College's new advice on treating hepatitis C virus (HCV) identifies patients who can be safely treated in primary care with laboratory monitoring limited to the beginning and end of treatment and no invasive testing.
https://immattersacp.org/weekly/archives/2020/10/06/4.htm
6 Oct 2020
First COVID-19 vaccine receives interim recommendation, hydroxychloroquine ineffective for prophylaxis, and more
The FDA issued an emergency use authorization for the first mRNA vaccine against SARS-CoV-2, and the CDC's Advisory Committee on Immunization Practices made an interim recommendation for its use in those ages 16 years and older. Other research looked at postexposure prophylaxis, household SARS-CoV-2 transmission, and persistent COVID-19 symptoms.
https://immattersacp.org/weekly/archives/2020/12/15/1.htm
15 Dec 2020
Latest data on COVID-19's potential treatments, effects on drug abuse and mortality
A living systematic review still only finds strong support for steroids, an antibody cocktail reduced viral load in outpatients, overdoses rose during lockdowns, and studies looked at loss of life from the pandemic.
https://immattersacp.org/weekly/archives/2020/12/22/2.htm
22 Dec 2020
New warning on NSAIDs; drug approved for flu exposures
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/01/new-warning-on-nsaids-drug-approved-for-flu-exposures.htm
1 Jan 2021